EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $558,530 | -30.6% | 28,731 | +1.3% | 0.00% | 0.0% |
| Q1 2023 | $804,913 | +4.9% | 28,372 | +8.0% | 0.00% | 0.0% |
| Q4 2022 | $767,550 | +3.2% | 26,259 | -6.7% | 0.00% | 0.0% |
| Q3 2022 | $744,000 | -0.1% | 28,150 | +68.0% | 0.00% | 0.0% |
| Q2 2022 | $745,000 | -14.6% | 16,757 | -4.9% | 0.00% | 0.0% |
| Q1 2022 | $872,000 | -8.0% | 17,613 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $948,000 | +2.6% | 18,625 | +12.4% | 0.00% | 0.0% |
| Q3 2021 | $924,000 | +203.9% | 16,568 | +119.4% | 0.00% | 0.0% |
| Q4 2018 | $304,000 | -76.3% | 7,551 | -64.8% | 0.00% | -66.7% |
| Q3 2017 | $1,281,000 | -35.6% | 21,472 | -14.8% | 0.00% | -40.0% |
| Q2 2017 | $1,989,000 | – | 25,213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |